University at Buffalo - The State University of New York
Skip to Content

Recent Research Funding

Our faculty research in diverse subjects: psychosomatic issues, pain management, patient reporting and compliance behaviors, whole community and family roles in psychiatric conditions and treatment, teaching strategies and much more.

Steven Dubovsky, MD

  • Randomized, double-blind, parallel-group, placebo-controlled, dose ranging study of piromelatine in patients with mild dementia due to Alzheimer’s disease. Steven Dubovsky (Principal Investigator). Neurim Pharmaceuticals. $150,000. 1/1/2016-1/1/2018.
  • Access to Psychiatry Through Intermediate Care (APIC). Steven Dubovsky (Principal Investigator). Tower Foundation. $1,300,000. 1/1/2015-1/1/2017.
  • Open-label, long-term safety study of vilazodone in pediatric patients with major depressive disorder. Steven Dubovsky (Principal Investigator). Forest Research Institute. $221,000. 1/1/2015-1/1/2018.

Bruce Miller, MD

  • Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators. Bruce Miller (Principal Investigator), Heather Lehman (Co-Investigator), Beatrice Wood (Principal Investigator). NIH/NHLBI. $3,987,363. 8/1/2015-7/1/2020.

Beth Smith, MD

  • Principle Investigator. Routine Depression Screening: Feasibility and Patient Outcomes in Cystic Fibrosis. Beth Smith (Principal Investigator). Cystic Fibrosis Foundation. $261,000. 1/1/2014-1/1/2017.

Beatrice Wood, PhD, ABPP

  • Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators. Beatrice Wood (Principal Investigator), Heather Lehman (Co-Investigator), Bruce Miller (Principal Investigator). NIH/NHLBI. $3,987,363. 8/1/2015-7/1/2020.